Page last updated: 2024-11-02

pentobarbital and Drug Refractory Epilepsy

pentobarbital has been researched along with Drug Refractory Epilepsy in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Research Excerpts

ExcerptRelevanceReference
"Retrospective chart review including children age 0-17 years who received pentobarbital infusion from 2003 to 2016 for status epilepticus."7.88Outcomes in Children Treated with Pentobarbital Infusion for Refractory and Super-Refractory Status Epilepticus. ( Anderson, A; Erklauer, J; Graf, J; Loftis, L; McPherson, M; Minard, CG; Wilfong, A, 2018)
"Retrospective chart review including children age 0-17 years who received pentobarbital infusion from 2003 to 2016 for status epilepticus."3.88Outcomes in Children Treated with Pentobarbital Infusion for Refractory and Super-Refractory Status Epilepticus. ( Anderson, A; Erklauer, J; Graf, J; Loftis, L; McPherson, M; Minard, CG; Wilfong, A, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erklauer, J1
Graf, J1
McPherson, M1
Anderson, A1
Wilfong, A1
Minard, CG1
Loftis, L1

Other Studies

1 other study available for pentobarbital and Drug Refractory Epilepsy

ArticleYear
Outcomes in Children Treated with Pentobarbital Infusion for Refractory and Super-Refractory Status Epilepticus.
    Neurocritical care, 2018, Volume: 29, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Drug Resistant Epilepsy; Female; Follow-Up Studies; GABA Modula

2018